Loading clinical trials...
Loading clinical trials...
A Multicentre, Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)
Conditions
Interventions
Lyophilized S95014
Locations
6
Russia
Regional Children Clinical Hospital
Chelyabinsk, Russia
Children Regional Clinical Hospital
Krasnodar, Russia
Russian Children Clinical Hospital
Moscow, Russia
Regional Children Hospital
Nizhny Novgorod, Russia
V.A. Almazov National Medical Research Center
Saint Petersburg, Russia
Regional Children Clinical Hospital
Yekaterinburg, Russia
Start Date
June 15, 2021
Primary Completion Date
January 23, 2023
Completion Date
January 23, 2023
Last Updated
December 29, 2023
NCT05376111
NCT04065399
NCT07295951
NCT05453500
NCT05442515
NCT03970096
Lead Sponsor
Institut de Recherches Internationales Servier
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions